University Of Virginia
Clinical trials sponsored by University Of Virginia, explained in plain language.
-
Immune cells armed with antibody tackle Hard-to-Treat cancers
Disease control Not yet recruitingThis study tests a new treatment for people with metastatic breast or prostate cancer that has stopped responding to standard therapies. The treatment uses the patient's own immune cells, which are collected, coated with a special antibody, and then given back through an IV. The …
Phase: PHASE1, PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC
-
Exercise plus weight loss drug: a better combo?
Disease control Not yet recruitingThis study looks at whether adding exercise to a weight loss medication (tirzepatide) helps people lose more weight and improve health markers like blood sugar and cholesterol. It will involve 24 adults aged 30-65 who are overweight or have obesity. Participants will take the med…
Phase: PHASE3 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC
-
New hope for sepsis: landmark trial targets Drug-Resistant infections in africa
Disease control Not yet recruitingThis study tests whether adding a steroid (hydrocortisone) and a powerful antibiotic combination to standard care can help more people with HIV survive sepsis, a life-threatening infection. The trial will enroll 344 adults in Africa who have sepsis and HIV. The goal is to find a …
Phase: PHASE3 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 01, 2026 18:03 UTC
-
New ultrasound could spot heart danger in cancer patients
Diagnosis Not yet recruitingThis early-phase study tests whether a special ultrasound with a targeted contrast agent (Sonazoid) can quickly diagnose heart inflammation caused by immune checkpoint inhibitor cancer drugs. About 30 adults who recently received these drugs and show signs of heart inflammation w…
Phase: EARLY_PHASE1 • Sponsor: University of Virginia • Aim: Diagnosis
Last updated Jun 12, 2026 12:06 UTC
-
Handheld ankle tester could revolutionize sprain diagnosis
Diagnosis Not yet recruitingThis study checks if a new portable ankle tester can reliably measure joint looseness in people with healthy ankles, past sprains, or chronic ankle instability. Researchers will also test it on people with fresh ankle sprains over their first month of recovery. The goal is to see…
Sponsor: University of Virginia • Aim: Diagnosis
Last updated Jun 11, 2026 12:12 UTC
-
New online program aims to prevent Alcohol-Related birth defects in native communities
Prevention Not yet recruitingThis study tests different combinations of an online program called CARRII to help Native women reduce their risk of alcohol-exposed pregnancy. 512 women who drink alcohol and are at risk for pregnancy will use the program for 3 months. The goal is to find the most effective and …
Phase: NA • Sponsor: University of Virginia • Aim: Prevention
Last updated Jun 16, 2026 12:49 UTC
-
Which ear gets the implant? new study aims to cut dizziness
Knowledge-focused Not yet recruitingThis study looks at 10 adults over 50 with hearing loss in both ears and a weak balance system on one side. Researchers want to see if putting a cochlear implant in the ear with worse balance leads to less dizziness after surgery. Participants are randomly assigned to get the imp…
Phase: NA • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC
-
Antibiotics may weaken immunity in malnourished babies
Knowledge-focused Not yet recruitingThis study looks at whether giving antibiotics to malnourished infants under 1 year old with diarrhea caused by certain viruses or parasites harms their immune system's ability to fight off future infections. Researchers will compare infants who receive usual care (including anti…
Phase: PHASE1 • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC